Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17442-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17442-1-AP, RRID:AB_2219662
- Product name
- ACADL antibody
- Antibody type
- Polyclonal
- Description
- ACADL antibody (Cat. #17442-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
A HIF-1α inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells.
The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury.
Lipidomics reveals the potential mechanism of honokiol against adenine-induced chronic kidney disease.
Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients.
Weng SW, Wu JC, Shen FC, Chang YH, Su YJ, Lian WS, Tai MH, Su CH, Chuang JH, Lin TK, Liou CW, Chu TH, Kao YH, Wang FS, Wang PW
Diabetologia 2023 May;66(5):913-930
Diabetologia 2023 May;66(5):913-930
A HIF-1α inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells.
Matsufuji S, Kitajima Y, Higure K, Kimura N, Maeda S, Yamada K, Ito K, Tanaka T, Kai K, Noshiro H
Cancer & metabolism 2023 Dec 8;11(1):25
Cancer & metabolism 2023 Dec 8;11(1):25
The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury.
Ma Y, Wang M, Guo S, Li T, Liu X, Zhao L
Frontiers in pharmacology 2022;13:1048728
Frontiers in pharmacology 2022;13:1048728
Lipidomics reveals the potential mechanism of honokiol against adenine-induced chronic kidney disease.
Liu X, Gao L, Huang X, Deng R, Wei X, Lu J, Li S
Frontiers in pharmacology 2022;13:1019629
Frontiers in pharmacology 2022;13:1019629
Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients.
Zhang YK, Qu YY, Lin Y, Wu XH, Chen HZ, Wang X, Zhou KQ, Wei Y, Guo F, Yao CF, He XD, Liu LX, Yang C, Guan ZY, Wang SD, Zhao J, Liu DP, Zhao SM, Xu W
Nature communications 2017 Sep 6;8(1):464
Nature communications 2017 Sep 6;8(1):464
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse kidney tissue were subjected to SDS PAGE followed by western blot with 17442-1-AP(ACADL antibody) at dilution of 1:1000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human kidney using 17442-1-AP(ACADL antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ACADL antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ACADL. This antibody recognizes human, mouse antigen. The ACADL antibody has been validated for the following applications: ELISA, WB, IHC analysis.
